Previous 10 | Next 10 |
It looks like Santa rally may finally come to the US Stock Market. Let’s take a look at some of the hot stocks on the big boards today. Shares of 22nd Century Group, Inc. (NASDAQ: XXII) gained $0.85 after the company announced that the U.S. Food and Drug Administration (FDA) has author...
Shares of 22nd Century Group (NASDAQ: XXII) soared 38.6% on Thursday after the U.S. Food and Drug Administration (FDA) authorized the company's VLN cigarette as a modified risk tobacco product (MRTP). The agricultural biotechnology-specialist's VLN products contain 95% less nico...
The FDA announced today that it authorized the marketing of 22nd Century Group’s Very Low Nicotine (VLN) Cigarettes. The company will now move forward with US manufacture and distribution of its VLN cigarettes within the next 90 days. 22nd Century Group already manufactures...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech company 22nd Century Group (NASDAQ: XXII ) must be smiling today after a recent U.S. Food and Drug Administration (FDA) designation has investors celebrating. Indeed, news broke today that the FDA approved mar...
Gainers: Zhangmen Education (NYSE:ZME) +474%. 22nd Century Group (NASDAQ:XXII) +49%. Pasithea Therapeutics (NASDAQ:KTTA) +36%. Theseus Pharmaceuticals (NASDAQ:THRX) +32%. Qualigen Therapeutics (NASDAQ:QLGN) +32%. Allakos (NASDAQ:ALLK) +27%. REE Automotive (NASDAQ:REE) +26%. View (NASDAQ:VIEW)...
VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP Designation FDA Adds Evidence-Based, Headline Claim “Helps You Smoke Less” to Company’s Requested Claims VLN® 95% Reduced Nicotine Content Cigarettes to Launc...
22nd Century Group (NASDAQ:XXII) rallies in early trading after the U.S. Food and Drug Administration approved marketing for the company's VLN King and VLN Menthol King combusted, filtered cigarettes as modified risk tobacco products. The distinction will help XXII advertise the products as h...
22nd Century and Aurora Cannabis made an agreement with Cronos Group to license their cannabinoid biosynthesis intellectual property. The agreement aims to scale up the production and development of rare cannabinoids like CBN, CBG, and CBC. There is competition from other cultured...
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group PR Newswire Licensing deal set to assist in the advancement of research and development for cannabinoid biosynthesis EDMONTON, AB , Dec. 14, 2021 /PRNewswire/ - Au...
New Zealand Ministry of Health announced aggressive measures to reduce smoking, including a reduced nicotine mandate by 2025 22nd Century fully engaged and ready to support New Zealand’s government as it takes bold steps to make country smokefree by 2025 BUF...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...